APA (7th ed.) Citation

Katodritou, E., Terpos, E., Kastritis, E., Delimpasis, S., Symeonidis, A., Repousis, P., . . . Gavriatopoulou, M. (2015). Lack of survival improvement with novel anti-myeloma agents for patients with multiple myeloma and central nervous system involvement: The Greek Myeloma Study Group experience. Annals of Hematology, 94(12), 2033. https://doi.org/10.1007/s00277-015-2484-y

Chicago Style (17th ed.) Citation

Katodritou, Eirini, et al. "Lack of Survival Improvement with Novel Anti-myeloma Agents for Patients with Multiple Myeloma and Central Nervous System Involvement: The Greek Myeloma Study Group Experience." Annals of Hematology 94, no. 12 (2015): 2033. https://doi.org/10.1007/s00277-015-2484-y.

MLA (9th ed.) Citation

Katodritou, Eirini, et al. "Lack of Survival Improvement with Novel Anti-myeloma Agents for Patients with Multiple Myeloma and Central Nervous System Involvement: The Greek Myeloma Study Group Experience." Annals of Hematology, vol. 94, no. 12, 2015, p. 2033, https://doi.org/10.1007/s00277-015-2484-y.